Correlation Between Abcellera Biologics and Envista Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Envista Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Envista Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and Envista Holdings Corp, you can compare the effects of market volatilities on Abcellera Biologics and Envista Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Envista Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Envista Holdings.

Diversification Opportunities for Abcellera Biologics and Envista Holdings

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Abcellera and Envista is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Envista Holdings Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Envista Holdings Corp and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Envista Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Envista Holdings Corp has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Envista Holdings go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Envista Holdings

Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the Envista Holdings. In addition to that, Abcellera Biologics is 1.58 times more volatile than Envista Holdings Corp. It trades about -0.05 of its total potential returns per unit of risk. Envista Holdings Corp is currently generating about -0.05 per unit of volatility. If you would invest  3,682  in Envista Holdings Corp on October 11, 2024 and sell it today you would lose (1,765) from holding Envista Holdings Corp or give up 47.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Abcellera Biologics  vs.  Envista Holdings Corp

 Performance 
       Timeline  
Abcellera Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.
Envista Holdings Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Envista Holdings Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Envista Holdings may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Abcellera Biologics and Envista Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcellera Biologics and Envista Holdings

The main advantage of trading using opposite Abcellera Biologics and Envista Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Envista Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Envista Holdings will offset losses from the drop in Envista Holdings' long position.
The idea behind Abcellera Biologics and Envista Holdings Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets